NCT05195710View on ClinicalTrials.gov

Preoperative Y-90 Radioembolization for Tumor Control and Future Liver Remnant Hypertrophy in Patients With Colorectal Liver Metastases

PHASE1RecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

November 16, 2022

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2026

Conditions
Metastases
Interventions
DRUG

Yttrium-90 (Y-90) resin microspheres

Given by scan

Trial Locations (1)

77030

RECRUITING

M D Anderson Cancer Center, Houston

Sponsors

Collaborators (1)

Sirtex Medical
All Listed Sponsors
collaborator

Sirtex Medical

INDUSTRY

lead

M.D. Anderson Cancer Center

OTHER